Renal Insufficiency, Chronic

35 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Renal Insufficiency, Chronic
Treatment and conditionWhere it standsTrials
10 GE Xenokidney for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Arm 2A: TRACT/MONO mTOR for kidney failure, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Arm 2B: TRACT/MONO CNI for kidney failure, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AZD7760 for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Belantamab mafodotin for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cagrilintide for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ChoironeX GalKO Porcine Thymokidney for kidney failure, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Clazakizumab for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Concomitant Renal and Urinary Bladder Allograft Transplantation for renal insufficiency, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elasomeran for renal insufficiency, chronicTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for kidney failure, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Empagliflozin for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney + Kidney Transplantation with Standard Care for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
GGTA1 KO Thymokidney for kidney failure, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HRS-1780 tablets for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
IGT-303 for renal insufficiency, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MSCs for renal insufficiency, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MT1013 for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Orforglipron for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for kidney failure, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Semaglutide + Cagrilintide for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sodium zirconium cyclosilicate for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Testosterone for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for renal insufficiency, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tozinameran for renal insufficiency, chronicTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
UKidney for kidney failure, chronicTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Upacicalcet for renal insufficiency, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Virtual Weight Management Coaching + Semaglutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Zigakibart for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ziltivekimab for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1